Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction

NCT01962246 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

169

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Oxaliplatin; Capecitabine
OTHER: Oxaliplatin; Capecitabine; concurrent radiotherapy

Sponsor

Hebei Medical University